Skip to main content

Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
beta blockers
Description

In this request, we examined counts of individuals with a beta blocker dispensing of interest among the pediatric population in the Sentinel Distributed Database (SDD). This request contains two reports:

  • Report 1: contains counts of individuals among the pediatric population with evidence of a new beta blocker dispensing.
  • Report 2: contains counts of individuals among the pediatric population without requiring evidence that a beta blocker dispensing be new.

The study period includes data from January 1, 2008 to September 30, 2021. We distributed this request to eight Sentinel Data Partners on March 28, 2022.

Deliverables (2)
Sentinel Modular Program Report: Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis, Report 1 Sentinel Modular Program Report: Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis, Report 2
Additional Details
FDA Center
CDER
Time Period
January 1, 2008 - September 30, 2021
Analysis Type
Descriptive
Population / Cohort
Individuals 0 to 17 years of age
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Analysis: Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis
Sentinel Drug Analysis: Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis
Presentation: Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database